The Philadelphia chromosome is a genetic marker created by a translocation between chromosomes 9 and 22, leading to the BCR-ABL fusion gene. This gene produces an abnormal protein that causes chronic myeloid leukemia (CML) by promoting uncontrolled cell division. It is both a diagnostic hallmark and a therapeutic target, making it central to the diagnosis and treatment of CML.
LinksContact Us
Thank you for visiting 3J Pharma Inc – Interactive Medical Corner. Please use the form below for general inquiries, collaborations, or website feedback.
Important: This form is not for patient-specific medical advice or emergency communication. Always consult your healthcare provider directly for clinical concerns.
SUBSCRIBE TO OUR NEWSLETTER
Error: Your Requested widget "Blog Subscriptions (Jetpack) " is not in the widget list.